CYCLOCYTIDINE, AN ANTITUMOR CYTIDINE ANALOG RESISTANT TO CYTIDINE DEAMINASEHOSHI A; KURETANI K.1979; GANN MONOGR. CANCER RES.; JPN; DA. 1979; NO 24; PP. 143-157; BIBL. 74 REF.Article

DIFFERENCES BETWEEN 5-FLUORO-2'-DEOXYURIDINE AND 5-FLUOROURIDINE IN THEIR CYTOTOXIC EFFECT ON GROWTH OF MURINE LYMPHOMA L5178Y CELLS IN IN VIVO AND IN VITRO SYSTEMSKANZAWA F; HOSHI A; KURETANI K et al.1980; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1980; VOL. 16; NO 8; PP. 1087-1092; BIBL. 21 REF.Article

THE DIFFERENCE IN MECHANISM OF ACTION OF 5-FLUOROURACIL AND ITS NUCLEOSIDES IN L5178Y CELLSYOSHIDA M; HOSHI A; KURETANI K et al.1980; J. PHARMACOBIO-DYN.; ISSN 0386-846X; JPN; DA. 1980; VOL. 3; NO 8; PP. 374-379; BIBL. 10 REF.Article

PREVENTION OF ANTITUMOR EFFECT OF 5-FLUOROURACIL BY HYPOXANTHINEYOSHIDA M; HOSHI A; KURETANI K et al.1978; BIOCHEM. PHARMACOL.; GBR; DA. 1978; VOL. 27; NO 24; PP. 2979-2982; BIBL. 8 REF.Article

INFLUENCE OF DURATION OF EXPOSURE TO 5-FLUOROURACIL ON ANTIPROLIFERATING ACTIVITY AGAINST CULTURED MURINE LYMPHOMACELLSKANZAWA F; HOSHI A; KURETANI K et al.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 44; NO 5; PP. 757-759; BIBL. 14 REF.Article

METABOLIC FATE OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AND 5-FLUOROURACIL IN MICE BEARING ASCITES SARCOMA 180IIGO M; KURETANI K; HOSHI A et al.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 66; NO 2; PP. 345-349; BIBL. 13 REF.Article

ISOLATION AND CHARACTERIZATION OF THE MURINE LYMPHOMA L5178Y CELL LINE HIGHLY RESISTANT TO 5-FLUOROURACILKANZAWA F; HOSHI A; KURETANI K et al.1980; J. PHARMACOBIO-DYN.; ISSN 0386-846X; JPN; DA. 1980; VOL. 3; NO 8; PP. 390-394; BIBL. 20 REF.Article

MODE OF ACTION OF 5-FLUOROURIDINE 5'-PHOSPHATE IN VIVO AND IN VITRO.YOSHIDA M; KURETANI K; HOSHI A et al.1978; CHEM. PHARM. BULL.; JAP.; DA. 1978; VOL. 26; NO 2; PP. 429-434; BIBL. 8 REF.Article

INFLUENCE OF ROUTE OF ADMINISTRATION OF ANTILEUKEMIC ACTIVITY OF CYCLOCYTIDINE = INFLUENCE DE LA VOIE D'ADMINISTRATION SUR L'ACTION ANTILEUCEMIQUE DE LA CYCLOCYTIDINEHOSHI A; KANZAWA F; KURETANI K et al.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 2; PP. 279-280; BIBL. 3 REF.Serial Issue

MECHANISM OF CYTOTOXICITY OF 5-FLUOROURACIL: DISTINCTION BETWEEN THE IRREVERSIBLE CYTOTOXIC EFFECT OF 5-FLUOROURIDINE AND THE REVERSIBLE CYTOTOXIC EFFECT OF 5-FLUORO-2'-DEOXYURIDINE ON MURINE LYMPHOMA L5178Y CELLS IN CULTUREKANZAWA F; HOSHI A; KURETANI K et al.1980; Z. KREBSFORSCH. KLIN. ONKOL.; ISSN 0084-5353; DEU; DA. 1980; VOL. 98; NO 1; PP. 85-90; BIBL. 18 REF.Article

ANTITUMOR ACTIVITY OF ALKYLESTERS OF 1-BETA -D-RIBOFURANOSYL-5-FLUOROURACIL-5'-PHOSPHATE AGAINST MURINE LYMPHOMA L5178Y RESISTANT TO 1-BETA -D-RIBOFURANOSYL-5-FLUOROURACILKAZAWA F; HOSHI A; KURETANI K et al.1979; BULL. CANCER; FRA; DA. 1979; VOL. 66; NO 5; PP. 497-501; ABS. FRE; BIBL. 13 REF.Article

EFFECT OF CENTROPHENOXINE ON CYCLOPHOSPHAMIDE CONCENTRATION IN BLOOD.KANZAWA F; HOSHI A; KURETANI K et al.1976; GANN; JAP.; DA. 1976; VOL. 67; NO 4; PP. 595-599; BIBL. 9 REF.Article

EFFECT OF STRUCTURAL MODIFICATION ON ANTITUMOR ACTIVITY OF HALOACETYLPHENOTHIAZINES = EFFET DE MODIFICATION STRUCTURALE SUR L'ACTIVITE ANTITUMORALE DES HALOACETYLPHENOTHIAZINESKANZAWA F; HOSHI A; KURETANI K et al.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 3; PP. 375-378; BIBL. 4REF.Serial Issue

EFFECT AND TOXICITY OF COMBINATION TREATMENT INCLUDING CYCLOCYTIDINE OR CYTOSINE ARABINOSIDE IN "L1210 AND SARCOMA-180 SYSTEMSHOSHI A; KANZAWA F; IIGO M et al.1975; GANN; JAP.; DA. 1975; VOL. 66; NO 5; PP. 539-546; BIBL. 12 REF.Article

ANTITUMOR ACTIVITY OF PROTEIN MOIETY OF PSEUDOMONAS AERUGINOSA ENDOTOXIN = ACTION ANTITUMORALE DE LA FRACTION PROTEIQUE DE L'ENDOTOXINE DE P. A.HOSHI A; KANZAWA F; KURETANI K et al.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 4; PP. 503-504; BIBL. 13 REF.Serial Issue

MURINE LYMPHOMA L5178Y CELLS RESISTANT TO PURINE ANTAGONISTS: DIFFERENCES IN CROSS-RESISTANCE TO THIOGUANINE-PLATINUM (II) AND SELENOGUANINE-PLATINUM (II)KANZAWA F; MAEDA M; SASAKI T et al.1982; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1982; VOL. 68; NO 2; PP. 287-291; BIBL. 25 REF.Article

PYRIMIDINE NUCLEOSIDES. VI. SYNTHESES AND ANTICANCER ACTIVITIES OF N⁴-SUBSTITUTED 2,2'-ANHYDRONUCLEOSIDESKANAI T; ICHINO M; HOSHI A et al.1974; J. MEDICIN. CHEM.; U.S.A.; DA. 1974; VOL. 17; NO 10; PP. 1076-1078; BIBL. 22 REF.Article

POTENTIATION OF ANTITUMOR ACTIVITY OF CYCLOPHOSPHAMIDE BY CENTROPHENOXINE = POTENTIALISATION DE L'ACTION ANTITUMORALE DU CYCLOPHOSPHAMIDE PAR LA CENTROPHENOXINEKANZAWA F; HOSHI A; TSUDA S et al.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 4; PP. 409-413; BIBL. 6 REF.Serial Issue

ANTITUMOR ACTIVITY OF 1-ACYLOXYMETHYL DERIVATIVES OF 5-FLUOROURACIL AGAINST L1210 LEUKEMIAHOSHI A; INOMATA M; KANZAWA F et al.1982; J. PHARMACOBIO-DYN; ISSN 0386-846X; JPN; DA. 1982; VOL. 5; NO 3; PP. 208-212; BIBL. 6 REF.Article

EFFECT OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL ON SPONTANEOUS MAMMARY ADENOCARCINOMA OF MICETOKUZEN R; IIGO M; HOSHI A et al.1980; GANN; ISSN 0016-450X; JPN; DA. 1980; VOL. 71; NO 5; PP. 724-728; BIBL. 11 REF.Article

METABOLIC FATE OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AFTER ORAL ADMINISTRATION IN MICEIIGO M; NAKAMURA A; KURETANI K et al.1980; XENOBIOTICA; ISSN 0049-8254; GBR; DA. 1980; VOL. 10; NO 11; PP. 847-854; BIBL. 8 REF.Article

ANTITUMOR ACTIVITY OF N-HETEROCYCLIC CARBOXALDEHYDE THIOSEMICARBAZONE DERIVATIVES.IIGO M; HOSHI A; KURETANI K et al.1977; GANN; JAP.; DA. 1977; VOL. 68; NO 2; PP. 221-225; BIBL. 5 REF.Article

DISTRIBUTION OF CYCLOCYTIDINE IN TISSUES.HOSHI A; IIGO M; KURETANI K et al.1975; CHEM. PHARM. BULL.; JAP.; DA. 1975; VOL. 23; NO 4; PP. 725-728; BIBL. 8 REF.Article

ANTITUMOR ACTIVITY OF CARBAMOYL DERIVATIVES OF 5-FLUOROURACIL BY ORAL ADMINISTRATIONHOSHI A; IIGO M; YOSHIDA M et al.1975; GANN; JAP.; DA. 1975; VOL. 66; NO 6; PP. 673-674; BIBL. 2 REF.Article

STRUCTURE-ANTITUMOR ACTIVITY RELATIONSHIP OF PURIN-6-YL ALKYL DISULFIDESINOMATA M; FUKUOKA F; HOSHI A et al.1981; J. PHARMACOBIO-DYN.; ISSN 0386-846X; JPN; DA. 1981; VOL. 4; NO 1; PP. 59-64; BIBL. 10 REF.Article